U.S. Markets open in 29 hrs, 5 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 32.87 09:31 AM EST | |
|---|---|---|
| Day High | 33.80 03:39 PM EST |
|
| Range | 0.93 |
| Volume | 269,311 | |
|---|---|---|
| 30-Day Avg Vol | 429,000 |
|
| Difference | -37.22% |
| Market Cap | 1.44 B | |
|---|---|---|
| Mkt Cap Chg | 20.96 M |
| Shares Out | 42.79 M | |
|---|---|---|
| % Shrs Traded | 0.63% | |
| 1yr EPS Est | -0.743 |
| 52-Wk Low | 17.96 | |
|---|---|---|
| 52-Wk High | 37.28 |
|
| Range | 19.32 |
| Prev Close | 33.23 11/5/09 | |
|---|---|---|
| Today's Open | 33.05 | |
| Change | -0.54% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.74 M |
| Revenue (LFY) | 125.37 M | |
|---|---|---|
| Earnings (LFY) | -46.29 M | |
| Earnings (MRQ) | -14.95 M | |
| Next Earn Est | -0.314 | |
| Next Earnings | 02/15/2010 |
|
| EPS (TTM) | -1.27 | |
| 1yr EPS Growth | 41.50% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -45.00 | |
| PEG Ratio | -1.50 | |
| Return on Equity | -93.19 | |
| Beta | 1.02 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Auxilium Pharmaceuticals is supplementing men's manliness. The company develops treatments for urological and sexual health. Auxilium's lone marketed product is Testim, a topical testosterone gel used ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.314 2/15/10 | — — |
—
—
|
| Last Quarter | -0.311 9/30/09 | -0.35 9/30/09 |
-0.039
Missed
|
| 2 Quarters Ago | -0.293 6/30/09 | -0.32 6/30/09 |
-0.027
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 42.14 M | 125.38 M |
| Gross Profit | 32.60 M | 95.89 M |
| Operating Income | -14.84 M | -48.09 M |
| Net Income | -14.95 M | -46.29 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts